Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20071
20081
20092
20102
20111
20152
20174
20192
20203
20211
20221
20233
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting9
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group3
Bristol-Myers Squibb2
Eli Lilly and Company2
NCIC Clinical Trials Group2
University of Saskatchewan2
AHS Cancer Control Alberta1
Abbott1
Auricula Biosciences Inc.1
CSA Medical, Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms30
Carcinoma, Non-Small-Cell Lung18
Neoplasms7
Breast Neoplasms6
Colorectal Neoplasms6
Head and Neck Neoplasms6
Carcinoma4
Colonic Neoplasms4
Neoplasms by Site4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.